Clinical Trial 15519

Miami, FL 33185

Study Summary:

The primary objective of this study is to determine whether a experimental drug called RESLIZUMAB administered once every 4 weeks, is more effective than a placebo in improving lung function.

Qualified Participants Must:

• Be between 12 and 25 years of age
• Have a previous diagnosis of Asthma
• Be currently taking, FLUTICASON
• Be on a stable dose for 30 days before Screening
• Must have a negative pregnancy test before Screening

Qualified Participants May Receive:

Qualified participants will recieve, a comensation of $50 dollars per each completed visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.